IS SERUM ANHYDROGLUCITOL AN ALTERNATIVE TO THE ORAL GLUCOSE-TOLERANCE TEST FOR DIABETES SCREENING

被引：29

作者：

ROBERTSON, DA ^{[1
]}

ALBERTI, KGMM ^{[1
]}

DOWSE, GK ^{[1
]}

ZIMMET, P ^{[1
]}

TUOMILEHTO, J ^{[1
]}

GAREEBOO, H ^{[1
]}

机构：

[1] HUMAN DIABET & METAB RES CTR,NEWCASTLE TYNE,ENGLAND

来源：

DIABETIC MEDICINE | 1993年 / 10卷 / 01期

关键词：

ANHYDROGLUCITOL; DEOXYGLUCOSE; DIABETES; SCREENING; DIAGNOSTIC TESTS; FRUCTOSAMINE; ORAL GLUCOSE TOLERANCE TEST;

D O I：

10.1111/j.1464-5491.1993.tb01997.x

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

The oral glucose tolerance test is inconvenient for diabetes screening. In clinical studies a reduced serum anhydroglucitol level has proved to be a sensitive and specific test for diabetes. A new minicolumn enzymatic method which is simple and robust makes use in population screening feasible. The aim of our study was to assess the usefulness of a single measurement of anhydroglucitol to screen for diabetes and impaired glucose tolerance. Assays were performed on samples taken from 227 Mauritian Chinese subjects at the time of glucose tolerance testing. Subjects had normal glucose tolerance (n = 82), impaired glucose tolerance (n = 76), newly diagnosed diabetes (n = 38), and known diabetes (n = 31). Anhydroglucitol concentrations (mean +/- SD) were similar for normal and impaired glucose tolerance subjects (23.7 +/- 8.2 vs 23.4 +/- 8.6 mg l-1). Although the differences between normal and newly diagnosed diabetes (15.0 +/- 11.0 mg l-1) and known diabetic subjects (11.8 +/- 10.6 mg 1-1) were significant (p < 0.001), diagnostic sensitivity and specificity were poor. We conclude that measurement of serum anhydroglucitol is not suitable for screening for the diagnoses of impaired glucose tolerance and diabetes.

引用

页码：56 / 60

页数：5

共 33 条

[11]

Harris MI, Hadden WC, Knowler WC, Bennett PH, International criteria for the diagnosis of diabetes and impaired glucose tolerance, Diabetes Care, 8, pp. 562-567, (1985)

[12]

Jennings PE, Barnett AH, New approaches to the pathogenesis and treatment of diabetic microangiopathy, Diabetic Med, 5, pp. 111-117, (1988)

[13]

Winegrad AI, Does a common mechanism induce the diverse complications of diabetes?, Diabetes, 36, pp. 396-406, (1987)

[14]

Pitkanen E, 1,5‐Anhydro‐D‐glucitol., A novel type of sugar in the human organism, Scandinavian Journal of Clinical and Laboratory Investigation, 50, pp. 55-62, (1990)

[15]

Yamanouchi T, Akanuma H, Asano T, Konishi C, Akaoka I, Akanuma Y, Reduction and recovery of plasma 1,5‐anhydro‐D‐glucitol level in diabetes mellitus, Diabetes, 36, pp. 709-715, (1987)

[16]

Yamanouchi T, Akanuma H, Nakamura T, Akaoka I, Akanuma Y, Reduction of plasma 1,5‐anhydroglucitol (1‐deoxyglucose) concentration in diabetic patients, Diabetologia, 31, pp. 41-45, (1988)

[17]

Yamanouchi T, Akanuma Y, Toyota T, Kuzuya T, Kawai T, Kawazu S, Et al., Comparison of 1,5‐anhydroglucitol, HbA<sub>1c</sub>, and fructosamine for detection of diabetes mellitus, Diabetes, 40, pp. 52-57, (1991)

[18]

Yabuuchi M, Masuda M, Katoh K, Nakamura T, Akanuma H, Simple enzymatic method for determining 1,5‐anhydro‐D‐glucitol in plasma for diagnosis of diabetes mellitus, Clin Chem, 35, pp. 2039-2043, (1989)

[19]

Dowse GK, Gareeboo H, Zimmet PZ, Alberti KGMM, Tuomilehto J, Fareed D, Et al., High prevalence of NIDDM and impaired glucose tolerance in Indian, Creole and Chinese Mauritians, Diabetes, 39, pp. 390-396, (1990)

[20]

Dowse GK, Zimmet PZ, Gareeboo H, Alberti KGMM, Tuomilehto J, Finch CF, Et al., Abdominal obesity and physical inactivity as risk factors for NIDDM and impaired glucose tolerance in Indian, Creole, and Chinese Mauritians, Diabetes Care, 14, pp. 271-282, (1991)

← 1 2 3 4 →